We are developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference. Nasdaq:SLN Guidelines: https://bit.ly/3iYc2sP
Location: United Kingdom, England, London
Member count: 11-50
Total raised: $40M
Founded date: 1994
Investors 1
Date | Name | Website |
- | MP Healthc... | mp-healthc... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
25.05.2021 | - | $40M | - | marketscre... |
Mentions in press and media 39
Date | Title | Description | Category | Author | Source |
22.02.2022 | Another bi... | Silence Therapeutics became th... | - | Max Gelman | endpts.com... |
05.01.2022 | Silence Th... | Silence Therapeutics to Partic... | - | - | globenewsw... |
12.12.2021 | New Data f... | New Data from SLN124 Healthy V... | - | - | globenewsw... |
01.12.2021 | Silence Th... | 1 December 2021 LONDON, Silen... | - | - | globenewsw... |
01.12.2021 | Silence Th... | 1 December 2021 LONDON, Silen... | - | - | marketscre... |
30.11.2021 | Silence Th... | Silence Therapeutics Begins Ex... | - | - | marketscre... |
26.11.2021 | Silence Th... | Silence Therapeutics plc: Upda... | - | - | marketscre... |
11.11.2021 | Silence Th... | Silence Therapeutics to Presen... | - | - | globenewsw... |
08.11.2021 | Silence Th... | LONDON, Silence Therapeutics p... | - | - | marketscre... |
05.11.2021 | Silence Th... | Silence Therapeutics Welcomes ... | - | - | marketscre... |
Show more